Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

TP 9201 MeSH Supplementary Concept Data 2025


MeSH Supplementary
TP 9201
Unique ID
C085362
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C085362
Entry Term(s)
TP-9201
TP9201
acetyl-L-cysteinyl-L-asparaginyl-L-propyl-L-arginyl-glycyl-L-alpha-aspartyl-o-methyl-L-tyrosyl-L-arginyl-L-cysteine amide, cyclic 1-9 sulfide
Registry Numbers
82SQF2EUDU
Related Numbers
138297-15-1
CAS Type 1 Name
L-Cysteinamide, N-acetyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-arginylglycyl-L-alpha-aspartyl-O-methyl-L-tyrosyl-L-arginyl-, cyclic (1-9)-disulfide
Heading Mapped to
*Peptides, Cyclic
Frequency
10
Note
a platelet integrin alphaIIbbeta3 (GPIIb/IIIa) antagonist; a synthetic RGD-containing cyclic peptide; may be effective in prevention of re-thrombosis after thromolytic therapy without adversely affecting hemostasis
Source
Coron Artery Dis 1993 Sep;4(9):809-17
Date of Entry
1994/02/18
Revision Date
2017/10/31
TP 9201 Preferred
acetyl-L-cysteinyl-L-asparaginyl-L-propyl-L-arginyl-glycyl-L-alpha-aspartyl-o-methyl-L-tyrosyl-L-arginyl-L-cysteine amide, cyclic 1-9 sulfide Broader
page delivered in 0.004s